Samuelsson, Jessica http://orcid.org/0000-0002-8891-6720
Najar, Jenna
Wallengren, Ola
Kern, Silke
Wetterberg, Hanna
Mellqvist Fässberg, Madeleine
Zetterberg, Henrik
Blennow, Kaj
Lissner, Lauren
Rothenberg, Elisabet
Skoog, Ingmar
Zettergren, Anna
Funding for this research was provided by:
the swedish state under the agreement between the swedish government and the county councils, the alf-agreement (ALFGBG-81392, ALFGBG-771071, ALF716681, ALFGBG-715986)
the alzheimerfonden (AF-842 471, AF-737641, AF-939825)
stiftelsen demensfonden
stiftelsen handlanden hjalmar svenssons
stiftelserna wilhelm och martina lundgrens
swedish research council (2018-02532, 11267, 2005-8460, 2007-7462, 2012-5041, 2015-02830, 2019-01096, 2013-8717, NEAR 2017-00639, 2017-00915)
the european research council (681712)
swedish state support for clinical research (ALFGBG-720931)
alzheimer's drug discovery foundation (201809-2016862, RDAPB-201809-2016615)
the ad strategic fund and the alzheimer's association (ADSF-21-831376-C, ADSF-21-831381-C, ADSF-21-831377-C)
the olav thon foundation
familjen erling-perssons stiftelse
stiftelsen för gamla tjänarinnor
hjärnfonden (FO2019-0228, FO2014-0207, FO2016-0214, FO2018-0214, FO2019-0163, FO2020-0235, FO2017-0243)
the european union’s horizon 2020 research and innovation programme under the marie skłodowska-curie grant agreement (No 860197)
the uk dementia research institute at ucl
stena foundation
swedish research council for health, working life and wellfare (2004-0145, 2006-0596, 2008-1111, 2010-0870, 2013-1202, 2018-00471, 2001-2646, 2003-0234, 2004-0150, 2006-0020, 2008-1229, 2012-1138, AGECAP 2013-2300, 2013-2496)
konung gustaf v:s och drottning victorias frimurarestiftelse
alzheimerfonden (AF-554461, AF-647651, AF-743701, AF-844671, AF-930868, AF-940139)
eivind och elsa k:son sylvans stiftelse
the alzheimer's association zenith award (ZEN-01-3151)
the alzheimer's association stephanie b. overstreet scholars (IIRG-00-2159)
the bank of sweden tercentenary foundation
stiftelsen söderström königska sjukhemmet
the swedish alzheimer foundation (AF-742881, AF-930582, AF-646061, AF-741361, AF-939988)
the european union joint program for neurodegenerative disorders (JPND2019-466-236)
instituto de pesquisa translacional em saúde e ambiente na região amazônica (1R01AG068398-01)
magnus bergvalls stiftelse
University of Gothenburg
Article History
Received: 7 July 2021
Accepted: 28 September 2021
First Online: 10 October 2021
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. SK has been consultant for Geras Solutions, unrelated to the findings in this manuscript. HZ has served at scientific advisory boards for Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, all outside the submitted work.
: Ethical approval was obtained from the Ethics Committee for Medical Research in Gothenburg, reference numbers 179–92, S22700, S37799, Ö40299 and S06901.
: The tenets of the Declaration of Helsinki were followed, and informed consent was obtained from all participants.
: Not applicable.